|
SPEN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8511999999582E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.09730000000952E-05 |
| Normal-vs-Stage2 |
1.655880E-03 |
| Normal-vs-Stage3 |
9.33839999994746E-07 |
| Normal-vs-Stage4 |
3.59589999999743E-05 |
| Stage1-vs-Stage2 |
7.386400E-01 |
| Stage1-vs-Stage3 |
1.590990E-01 |
| Stage1-vs-Stage4 |
2.397000E-01 |
| Stage2-vs-Stage3 |
5.207200E-01 |
| Stage2-vs-Stage4 |
6.147600E-01 |
| Stage3-vs-Stage4 |
9.413800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77259999999402E-05 |
| Normal-vs-AfricanAmerican |
1.102770E-01 |
| Normal-vs-Asian |
4.980900E-04 |
| Caucasian-vs-AfricanAmerican |
2.202800E-01 |
| Caucasian-vs-Asian |
9.900800E-01 |
| AfricanAmerican-vs-Asian |
2.396800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.200399999574E-07 |
| Normal-vs-Female |
2.25600000000048E-05 |
| Male-vs-Female |
3.129800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.000000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.37529999999042E-05 |
| Normal-vs-Age(61-80Yrs) |
2.41720000004886E-06 |
| Normal-vs-Age(81-100Yrs) |
6.197600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.759600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.457220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.699600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.805200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.729400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.503000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.222000E-02 |
| Classical-VS-Follicular |
5.921400E-03 |
| Classical-VS-Other |
2.144200E-01 |
| Classical-VS-Normal |
2.225700E-04 |
| Tall-VS-Follicular |
7.865000E-01 |
| Tall-VS-Other |
8.752800E-01 |
| Tall-VS-Normal |
3.8132000000024E-05 |
| Follicular-VS-Other |
8.063000E-01 |
| Follicular-VS-Normal |
4.13210000005382E-06 |
| Other-VS-Normal |
1.592360E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92834999999114E-05 |
| Normal-vs-N1 |
1.88126999999261E-05 |
| N0-vs-N1 |
3.744200E-01 |
|
|
